Literature DB >> 8682683

The pathogenesis of septic shock.

S R Crowley1.   

Abstract

A new age of treating patients with septic shock is rapidly approaching. A multidrug approach will likely be used to interrupt the systemic inflammatory response to infection, with use of new immune and inflammatory modulating therapies. In this article are reviewed the advances made in understanding the cellular events that cause septic shock. Critical care nurses need to update themselves on this new information to provide optimal care that patients with septic shock demand. Symptoms of septic shock, its hemodynamic characteristics, and the actions of principal inflammatory mediators that cause vasodilation and capillary leak are discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8682683     DOI: 10.1016/s0147-9563(96)80114-2

Source DB:  PubMed          Journal:  Heart Lung        ISSN: 0147-9563            Impact factor:   2.210


  2 in total

1.  Lipopolyamines: novel antiendotoxin compounds that reduce mortality in experimental sepsis caused by gram-negative bacteria.

Authors:  S A David; R Silverstein; C R Amura; T Kielian; D C Morrison
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

2.  Low-dose plasmid DNA treatment increases plasma vasopressin and regulates blood pressure in experimental endotoxemia.

Authors:  Thiago Malardo; Marcelo E Batalhão; Ademilson Panunto-Castelo; Luciana P Almeida; Everton Padilha; Isabela C Fontoura; Célio L Silva; Evelin C Carnio; Arlete A M Coelho-Castelo
Journal:  BMC Immunol       Date:  2012-11-08       Impact factor: 3.615

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.